| 1 | [SID855556] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID855556] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID855556] | Active | | | 96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia. [AID463189, Type: screening] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Active | | BioAssay | 96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia. | | AID | 463189 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID855556] | Active | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID855556] | Active | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 6 | [SID8149735] | Unspecified | | | Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) [AID1599, Type: other] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) | | AID | 1599 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID8149735] | Unspecified | | | Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) [AID1603, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) | | AID | 1603 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID8149735] | Unspecified | | | Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) [AID1604, Type: other] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) | | AID | 1604 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID8149735] | Unspecified | | | Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) [AID1605, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) | | AID | 1605 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID8149735] | Unspecified | | | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) | | AID | 1612 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID8149735] | Unspecified | | | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) | | AID | 1613 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID8149735] | Unspecified | | | Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) | | AID | 1614 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID8149735] | Unspecified | | | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) [AID1616, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) | | AID | 1616 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID8149735] | Unspecified | | | Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) | | AID | 1583 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID8149735] | Unspecified | | | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 8149735 | | CID | 73957 | | Outcome | Unspecified | | BioAssay | Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) | | AID | 1593 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID855556] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 17 | [SID855556] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 18 | [SID855556] | Inactive | Potency | 0.3548 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | 0.3548 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 19 | [SID855556] | Inactive | Potency | 1.4716 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | 1.4716 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID26748507] | Inactive | Potency | 12.5893 | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) [AID881, Type: confirmatory] | Arachidonate 15-lipoxygenase B [gi:317373425] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26748507 | | CID | 73957 | | Outcome | Inactive | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2) | | AID | 881 | | BioAssay type | confirmatory | | Target | Arachidonate 15-lipoxygenase B [gi:317373425] | | PubMed | | | Data Table |  |
|
| 21 | [SID26748507] | Inactive | Potency | 12.5893 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26748507 | | CID | 73957 | | Outcome | Inactive | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 22 | [SID26748507] | Inactive | Potency | 12.5893 | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID927, Type: confirmatory] | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26748507 | | CID | 73957 | | Outcome | Inactive | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 927 | | BioAssay type | confirmatory | | Target | ubiquitin carboxyl-terminal hydrolase 2 isoform a [Homo sapiens] [gi:188528692] | | PubMed | | | Data Table |  |
|
| 23 | [SID855556] | Inactive | Potency | 39.8107 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | 39.8107 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 24 | [SID144204028] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 144204028 | | CID | 73957 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 25 | [SID855556] | Inactive | | | Mycobacterium tuberculosis Pantothenate Synthetase Assay [AID375, Type: confirmatory] | Chain A, Crystal Structure Of A Pantothenate Synthetase, Apo Enzyme In C2 Space Group [gi:90108679] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Mycobacterium tuberculosis Pantothenate Synthetase Assay | | AID | 375 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of A Pantothenate Synthetase, Apo Enzyme In C2 Space Group [gi:90108679] | | PubMed | | | Data Table |  |
|
| 26 | [SID26748507] | Inactive | Potency | | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26748507 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 27 | [SID855556] | Inactive | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID855556] | Inactive | Potency | | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID855556] | Inactive | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID855556] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID855556] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID855556] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID855556] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID855556] | Inactive | Potency | | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID855556] | Inactive | Potency | | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 36 | [SID855556] | Inactive | | | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) [AID493027, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1) | | AID | 493027 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 37 | [SID855556] | Inactive | | | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID493035, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 493035 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 38 | [SID855556] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 39 | [SID855556] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 [AID488922, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 | | AID | 488922 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 40 | [SID855556] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). [AID2130, Type: screening] | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). | | AID | 2130 | | BioAssay type | screening | | Target | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] | | PubMed | | | Data Table |  |
|
| 41 | [SID26748507] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26748507 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 42 | [SID26748507] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26748507 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 43 | [SID855556] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 44 | [SID855556] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 45 | [SID855556] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. [AID504734, Type: screening] | toll-like receptor 9 [Homo sapiens] [gi:194068499] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. | | AID | 504734 | | BioAssay type | screening | | Target | toll-like receptor 9 [Homo sapiens] [gi:194068499] | | PubMed | | | Data Table |  |
|
| 46 | [SID855556] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. [AID504734, Type: screening] | toll-like receptor 9 [Homo sapiens] [gi:194068499] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. | | AID | 504734 | | BioAssay type | screening | | Target | toll-like receptor 9 [Homo sapiens] [gi:194068499] | | PubMed | | | Data Table |  |
|
| 47 | [SID855556] | Inactive | | | Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3) [AID1448, Type: screening] | MCOLN3 protein [Homo sapiens] [gi:38174238] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3) | | AID | 1448 | | BioAssay type | screening | | Target | MCOLN3 protein [Homo sapiens] [gi:38174238] | | PubMed | | | Data Table |  |
|
| 48 | [SID855556] | Inactive | | | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity [AID602252, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity | | AID | 602252 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] | | PubMed | | | Data Table |  |
|
| 49 | [SID855556] | Inactive | | | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity [AID602252, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity | | AID | 602252 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] | | PubMed | | | Data Table |  |
|
| 50 | [SID855556] | Inactive | | | Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity [AID504414, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform a [Homo sapiens] [gi:9966877] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 855556 | | CID | 73957 | | Outcome | Inactive | | BioAssay | Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504414 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform a [Homo sapiens] [gi:9966877] | | PubMed | | | Data Table |  |
|